Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT02848781
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT02848781
-
- Other papers using this trial's data
- First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, China, Japan, South Korea, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT02848781. Randomized; no masking; primary purpose treatment. Start 2015-11-30 (actual); primary completion 2021-03-29 (actual). Results posted on 2022-12-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial
- Acronym
- PAUSE-SCD
- Condition
- Ventricular Tachycardia (VT)
- Intervention (Device)
- Implantable Cardioverter Defibrillator (ICD)
- Intervention (Procedure)
- Catheter Ablation
- Lead sponsor
- University of Arizona
Record details
- Record id
cardio:ct-nct02848781- Content hash
6c0230a3398c451ffd1713db174a14024b43bd3518812f186098bffaa2fd5175